Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Merck CEO Frazier Vows ‘Tough’ Use of Spending for Innovation
Bloomberg
Thursday, January 6, 2011 - 12:40pm
tags:
Merck, Pharma CEOs, Kenneth Frazier, innovation
5-Star Stocks Poised to Pop: Abbott Labs
Motley Fool
Thursday, January 6, 2011 - 12:39pm
tags:
Abbott Laboratories
Merck Beats Vertex to FDA Hep C Filing
TheStreet.com
Thursday, January 6, 2011 - 12:38pm
tags:
Merck, Vertex Pharmaceuticals, FDA, hepatitis C
Bayer Seeks Approval for Xarelto
Yahoo/Zacks.com
Thursday, January 6, 2011 - 12:36pm
tags:
Bayer, Xarelto, JNJ, Pfizer, Bristol-Myers Squibb, blood thinners
Seattle Genetics in $8M deal with Pfizer
Bizjournals.com
Thursday, January 6, 2011 - 12:16pm
tags:
Pfizer, Seattle Genetics, ADC products
How Managing Decline Is Becoming a Key Skill in the Drug Business
BNET Pharma
Thursday, January 6, 2011 - 8:04am
tags:
layoffs
Basilea Rises Most in 11 Months on Takeover Speculation
Bloomberg
Thursday, January 6, 2011 - 8:02am
tags:
Basilea, M&A
The World's Most-Watched Pharma
Motley Fool
Thursday, January 6, 2011 - 8:01am
tags:
JNJ, Pfizer, Abbott Laboratories, Merck, Teva Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly
Inspire Pharmaceuticals: Looking for Inspiration Following Denufosol Failure
Seeking Alpha
Thursday, January 6, 2011 - 7:43am
tags:
Inspire, denufosol, cystic fibrosis
Why Cerus Is My Stock of the Year
Motley Fool
Thursday, January 6, 2011 - 7:42am
tags:
Cerus
Merck Ends Drug Research Pact With Ranbaxy, Economic Times Says
Bloomberg
Thursday, January 6, 2011 - 7:41am
tags:
Merck, Ranbaxy
Spectrum Pharma Jumps in With the Big Dogs
Motley Fool
Thursday, January 6, 2011 - 7:40am
tags:
Spectrum Pharmaceuticals, Roche, biosimilars, Biogen Idec, Rituxan
Roche Wins Broader U.S. Approval for Actemra Arthritis Drug
Bloomberg
Thursday, January 6, 2011 - 7:39am
tags:
Actemra, Roche, arthritis
Does United Therapeutics Miss the Grade?
Motley Fool
Thursday, January 6, 2011 - 7:33am
tags:
United Therapeutics, Teva Pharmaceuticals, GSK, Pfizer
A Pregnant Pause Over A Merck Contraceptive
Pharmalot
Wednesday, January 5, 2011 - 12:12pm
tags:
Merck, Implanon, UK, contraceptives
Birmingham court to oversee nearly 1200 Pfizer lawsuits over Chantix
Birmingham News, AL
Wednesday, January 5, 2011 - 11:51am
tags:
Alabama, Pfizer, Chantix, lawsuits, smoking cessation
Mann doubles down on biotech as Afrezza decision looms
Fierce Biotech
Wednesday, January 5, 2011 - 11:49am
tags:
diabetes, MannKind, inhaled insulin, Afrezza
Will hedge funds back pharma whistleblowers?
Fierce Pharma
Wednesday, January 5, 2011 - 11:44am
tags:
hedge funds, whistleblowers, GSK
Avastin raises heart failure risk in breast cancer
Reuters
Wednesday, January 5, 2011 - 11:43am
tags:
Roche, Avastin, heart failure, breast cancer
Drug indexes dip; Sinovac falls on downgrade
Marketwatch
Wednesday, January 5, 2011 - 11:42am
tags:
Sinovac, drug stocks

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.